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Peripheral Primitive Neuroectodermal Tumors (PNETs) are rare lesions that arise from outside the central
nervous system and normally do not affect the genitourinary system. Primary renal presentations are
extremely rare but given their aggressive behavior and characteristic cytomorphologic and genetic
features should be considered well-deﬁned distinct clinical entities in order to distinguish them from
other primary tumors featuring round cells in the kidney. We report one case of PNET involving the
kidney and associated with pregnancy.
 2015 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Ewing Sarcoma/Primitive Neuroectodermal Tumor family
represents 1% of all sarcomas and consists of Ewing Sarcoma
(ES), Primitive Neuroectodermal Tumor (PNET) and Askin Tumor.
These three distinct entities are characterized by common
cytomorphologic, immunohistochemical and molecular patho-
logic features.1 PNETs are presumed to arise from the cells of the
primitive neuroectoderm located in the neural crest.2 Tumors
located outside the central nervous system, whose most com-
mon presentation is as a bone or soft tissue mass in the chest
wall or paraspinal regions in adolescents and young adults,1e3
are categorized as peripheral PNETs (pPNETs). Although very
unusual, several genitourinary locations including uterus, cervix,
ovary, testis, epididymis, bladder and kidney have been docu-
mented.2 Renal Primitive Neuroectodermal Tumors (rPNETs)
have an extremely low incidence and thus most of the literature
consists of isolated case reports. The few cases reported
described a variable presentation, more aggressive behavior and
association with a higher mortality than in any other location.2Brady Urological Institute,
dicine, 600 N. Wolfe Street,
article under the CC BY-NC-ND liHere we present the case of a 33-year-old pregnant woman
with rPNET.Case presentation
A primiparous 33-year-old woman was in her usual state of
health until she presented during the 24th week of her second
pregnancy complaining of left groin pain in June of 2014. An
ultrasonography examination revealed a large left renal mass, and
subsequent MRI demonstrated a 3.5  5.2 cm in the mid and lower
pole of the left kidney located in the medial and posterior position
that exerted a mass effect on the renal sinus without venous
involvement (Fig. 1). Past medical history was remarkable for suc-
cessfully treatment for Hodgkin lymphoma with 6 cycles of ABVD
chemotherapy regimen, consisting of Adriamycin, Bleomycin,
Vinblastine and Dacarbazine, in 2004 and a follow-up abdominal CT
scan from November 2012 could be compared proving the renal
mass was not present at that time. A family history of olfactory
neuroblastoma was also reported. The patient was referred to our
Urology department, and after having thoroughly discussed the
likelihood of malignancy, evaluated the options available as well as
the associated risks, decided to schedule an elective delivery then
undergo radical nephrectomy. A presurgical MRI in August 2014
demonstrated a signiﬁcant increase in tumor size to 4.4  7.2 cm
within 42 days (Fig.1). Hence, at 32weeks of gestation the babywas
delivered and 1 week later the patient underwent robot assistedcense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Figure 1. Coronal T2-weighted abdominal magnetic resonance imaging (MRI) demonstrated a large mass (arrows) in the mid and lower pole of the left kidney (A). Axial T1-
weighted abdominal MRI revealed the tumor was located in the medial and posterior position and exerted a mass effect on the renal sinus without venous involvement (B).
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Surgical pathological report revealed a small round blue cells tumor
of 8 cm consistent with PNET in which the bulk of the lesion was
contained within the renal hilum and no extracapsular extension
(Fig. 2). Immunochemical studies were performed supporting the
previous diagnosis (Fig. 3). At her most recent follow-up in
September 2014, 4 weeks after surgery, CT/PET scan results
demonstrated no abnormal FDG activity in the remainder of the soft
tissue or osseous structures to suggest metastatic disease. The pa-
tient was scheduled to initiate adjuvant chemotherapy.Discussion
Primary renal PNETs are a rare and aggressive entity, usually
characterized by an advanced stage at the time of diagnosis.1 More
than 50% of the rPNET cases either develop local recurrence or
metastatic disease, with lymph node, liver and lung the most
frequent sites.3 Mean age at diagnosis is 26 years and the 5-year
disease-free survival has been reported to be 45e55%.3 The exis-
tence of other primary malignancies featuring round cells, associ-
ated with the uncommon nature of these malignancies, can lead to
misdiagnosis.1 rPNETs require a more extensive therapeutic
approach as compared to other comparable tumors of the kidneyFigure 2. Macroscopic examination of the specimen.such as Wilms tumor, monophasic synovial sarcoma, lymphoma,
clear cell sarcoma of the kidney, small cell carcinoma, neuroblas-
toma or desmoplastic small round cell tumor.1 Deﬁnitive diagnosis
of rPNET should be conﬁrmed based on histologic features that
include small uniform round cell morphology associated to a vari-
able level of rosette formation,3 molecular markers for trans-
locations resulting in a fusion transcript of the EWS gene and the
ETS-related family of oncogenes,1,3 as well as immunohistochem-
istry staining.2 This tumor was partially positive for S-100, focally
positive for NSE, strongly positive for CD99 and negative for syn-
aptophysin, chromogranin, WT-1, desmin, myogenin, CD45, AE1/
AE3 and CAM5.2. Clinical management includes resection associ-
ated with adjuvant chemotherapy.2 The current standard of care
remains the intensive multidrug chemotherapy regimen published
by Grier et al in NEJM in 2003, which includes 5 cycles of vincris-
tine, doxorubicin and Cytoxan, followed by 7 cycles of ifosfamide
and etoposide and 2 cycles of vincristine and Cytoxan.4 Despite the
limited evidence regarding pPNETs available in the literature,
several cases associated with pregnancy have been reported in
different locations including ovary, cervix, brain and pancreas.5 One
case of rPNET has been previously described in a pregnant woman.5
This association might suggest a possible effect of hormones on
PNETs during pregnancy, but this association still remains unclear.
This patient presented with a personal history of HodgkinFigure 3. Microscopic examination of tumor tissue showed sheets of tumor cells
entrapping tubules (A) composed of monotonous cells with round, vesicular nuclei
with ﬁne chromatin, small nucleoli, and indistinct cell borders. Tumor cells in a
pseudorosette pattern and areas of necrosis were common within the tumor. Cyto-
plasmic clearing was also present due to the presence of glycogen (B). Tumor cells
exhibited diffuse, membranous positivity for CD99 supporting the diagnosis (C).
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another rare entity whose origin is located in the neural crest.
Conclusion
Renal PNETs should be considered in the differential diagnosis of
rapidly growing renal mass with aggressive presentation, especially
during pregnancy.Conﬂict of interest
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